The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID

Madrid Health Service

Status: Completed

Conditions: Drug Users; Hepatitis C; HIV; Harm Reduction

Treatments: Other: Screening for HCV in PWID and Linkage-To-Care

Study type: Observational

Funder types: Other

Identifiers

NCT02971488

HUIL 15/03

Details and patient eligibility

About

Screening, diagnosis and treatment of HCV in PWID, should be part of a harm reduction strategy. Treatment of HCV infected PWID should be delivered in a multidisciplinary care setting with services to reduce the risk of reinfection and for management of the common social and psychiatric comorbidities in this population. More frequent diagnosis, new methods that prevent loss of tracking, and access to antiviral treatment are all strategies that must be implemented jointly if the prevalence of HCV infection in our setting is to be reduced.

Enrollment: 529 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• PWID
• >18 years of age
• Signed consent form

Exclusion Criteria:

Trial design

529 participants in 1 patient group

Persons who inject drugs (PWID)

Description:

The study population comprises persons who visit the Cañada Real Galiana shantytown on the outskirts of Madrid, where 90% of illegal drugs in the region are sold and consumed.

Treatment:

Other: Screening for HCV in PWID and Linkage-To-Care